Aquestive Therapeutics, Inc. AQST Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s total liabilities & equity?
- Aquestive Therapeutics, Inc. (AQST) reported total liabilities & equity of $141.13M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Aquestive Therapeutics, Inc.'s total liabilities & equity increased by 38.0% year-over-year, from $102.23M to $141.13M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s total liabilities & equity has grown at a 20.6% compound annual growth rate (CAGR), from $62.88M to $160.43M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.